Skip to main content
Clinical Trials/JPRN-UMIN000003898
JPRN-UMIN000003898
Not yet recruiting
未知

A randomized study of the influence of proton pump inhibitors on antiplatelet effect by Clopidogrel based on CYP2C19 genotypes - CYP2C19, Clopidgrel and Proton Pump Inhibitor Estimation study(CYCLON study)

ational Cerebral and Cardiovascular Center0 sites150 target enrollmentJuly 20, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
Angina pectoris and myocardial infarction
Sponsor
ational Cerebral and Cardiovascular Center
Enrollment
150
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 20, 2010
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational Cerebral and Cardiovascular Center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) the patient of severe liver disease 2\) the patient of severe renal disease 3\) the patient of congenital heart disease 4\) the patient of myocardial infarction within 3 months from onset or of severe cardiac function 5\) the patient of endocrine disease 6\) the patient of malignant or inflammatory disease 7\) the patient of severe respiratory disease including idiopathic pulmonary artery hypertension 8\) the patient of impaired activities of daily living by neurological or orthopedic disease 9\) the patient of severe hypertension 10\) the patient who taking corticosteroid or immunosuppressive drug 11\) the patient of type 1 diabetes mellitus 12\) the patient pregnant or probable of pregnancy 13\) the catecholamine injected patient 14\) the patient of symptomatic hypotension 15\) the patient with left ventricular outflow tract obstruction, hypertrophic obstructive cardiomyopthy or aortic stenosis, effecting hemodynamics significantly 16\) the patient who is judged inappropriate for any reason by doctor

Outcomes

Primary Outcomes

Not specified

Similar Trials